Financhill
Back

P3 Health Partners Quote, Financials, Valuation and Earnings

Sell
21

PIII
P3 Health Partners

Last Price:
0.53
Seasonality Move:
-9.28%

7 Day Trial

ALL ACCESS PASS

$ 7

P3 Health Partners Price Quote

$0.53
-0.02 (-3.11%)
(Updated: May 21, 2024 at 6:55 PM ET)

P3 Health Partners Key Stats

Sell
21
P3 Health Partners (PIII) is a Sell

Day range:
$0.54 - $0.60
52-week range:
$0.44 - $5.56
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.09
P/B ratio:
0.45%

Volume:
108.5K
Avg. volume:
355.5K
1-year change:
-85.79%
Market cap:
$65.4M
Revenue:
$1.3B
EPS:
$-0.61

How Much Does P3 Health Partners Make?

Is P3 Health Partners Growing As A Company?

  • What Is P3 Health Partners's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.29%
  • What Is P3 Health Partners's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

P3 Health Partners Stock Price Performance

What Is P3 Health Partners 52-Week High & Low?

P3 Health Partners Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy P3 Health Partners?

  • How Much Debt Does P3 Health Partners Have?
    Total long term debt quarterly is $119.6M
  • How Much Cash Does P3 Health Partners Have?
    Cash and short term investments quarterly total is $27.3M
  • What Is P3 Health Partners’s Book Value Per Share?
    Book value per share is 1.23

Is P3 Health Partners Cash Flow Positive?

  • What Is PIII Cash Flow From Operations?
    Cash flow from operations (TTM) is -$72.3M
  • What Is P3 Health Partners’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $97.6M
  • What Is P3 Health Partners’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$1.4M

P3 Health Partners Return On Invested Capital

  • Is Management Doing A Good Job?
    PIII return on invested capital is -11.7%
  • What Is P3 Health Partners Return On Assets?
    ROA measures how assets are converting to revenues and is -7.66%
  • What Is PIII Return On Equity?
    ROE is a measure of profitability and is -15.39%

P3 Health Partners Earnings Date & Stock Price

P3 Health Partners Competitors

  • Who Are P3 Health Partners's Competitors?
    Below is a list of companies who compete with P3 Health Partners or are related in some way:
    • American Shared Hospital Services (AMS)
    • Astrana Health Inc (ASTH)
    • Biote Corp (BTMD)
    • Cryo-Cell International Inc (CCEL)
    • Novo Integrated Sciences Inc (NVOS)

P3 Health Partners Dividend Yield

Data Unavailable

P3 Health Partners Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 28.61% 8.77%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 2.70
Upside from Last Price: 393.6%

Major Shareholders

  • How many PIII shares are owned by institutional investors?
    35.3M PIII shares are owned by institutional investors
  • How many PIII shares are owned by insiders?
    6.6M PIII shares are owned by insiders